相关实验视频

Updated: Jul 7, 2026

Isolation of Functional Cardiac Immune Cells

Isolation of Functional Cardiac Immune Cells

Published on: December 5, 2011

心脏沙丘病中的TNFα抑制剂:系统性审查和元分析

Asma Mahmood¹, Mahnoor Farooq Raja¹, Habiba Imran²

¹From the Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan.

Critical pathways in cardiology

|January 8, 2025

概括

瘤坏死因子 (TNF) α抑制剂显著改善心脏类瘤 (CS) 患者的射出分数并减少类固醇剂量. 需要进一步的研究来确认CS治疗的这些有希望的结果.

科学领域:

心脏病学心脏病学
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

心脏型硬化症 (CS) 通常用皮质类固醇治疗.
瘤坏死因子 (TNF) α抑制剂代表了CS的新治疗途径.

研究的目的:

为了评估TNFα抑制剂与其他治疗方法相比,在心力衰竭的CS患者中TNFα抑制剂的疗效.
评估TNFα抑制剂对射出分数,类固醇剂量和心脏成像发现的影响.

主要方法:

在主要数据库 (PubMed,Cochrane图书馆,Science Direct) 进行了系统的文献搜索.
随机效应建模用于对已识别的研究进行聚合分析.
研究包括心力衰竭的CS患者,将TNFα抑制剂与其他药物进行比较.

主要成果:

TNFα抑制剂显著增加了喷射分数 (EF) (WMD, 46.272; P < 0.001).
治疗导致6个月和12个月的普得尼松剂量显著降低 (P < 0.001).
pozitron 发射断层扫描显示心肌吸收值下降 (P < 0.001).

结论:

TNFα抑制剂在改善心脏功能和减少CS中皮质类固醇依赖方面显示出潜在的潜力.
需要进一步进行高质量,大规模的随机对照试验,以充分阐明TNFα抑制剂在CS中的益处.

更多相关视频

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

相关概念视频

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

Heart Failure Drugs: Inotropic Agents

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...